HSTM

HealthStream Inc

Add to Watchlist

Advanced Chart

26.680

+0.19(0.717%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

26.750

Open

26.520

VWAP

26.52

Vol

217.30K

Mkt Cap

790.83M

Low

26.390

Amount

5.76M

EV/EBITDA(TTM)

9.20

Total Shares

30.40M

700.21M

EV/OCF(TTM)

11.23

P/S(TTM)

2.76

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

75.57M

+3.39%

0.180

-5.26%

76.45M

+2.99%

0.190

+18.75%

75.76M

+3.1%

0.180

+28.57%

Estimates Revision

The market is revising Downward the revenue expectations for HealthStream, Inc. (HSTM) for FY2025, with the revenue forecasts being adjusted by -0.11% over the past three months. During the same period, the stock price has changed by -8.41%.

Revenue Estimates for FY2025

Revise Downward

-0.11%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+3.47%

In Past 3 Month

Stock Price

Go Down

-8.41%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast HSTM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSTM is 34.50 USD with a low forecast of 29.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

2 Hold

0 Sell

Moderate Buy

Current: 26.680

Low

29.00

Averages

34.50

High

40.00

Current: 26.680

Low

29.00

Averages

34.50

High

40.00

Canaccord

Hold

downgrade

$29 -> $28

2025-08-07

Reason

Canaccord

Price Target

$29 -> $28

2025-08-07

downgrade

Hold

Reason

Canaccord lowered the firm's price target on HealthStream to $28 from $29 and keeps a Hold rating on the shares. The firm said they reported a solid bounce back quarter following a disappointing 1Q report in back in May. Four of the five delayed deals cited last quarter crossed the finish line in 2Q, with the fifth expected to be closed in 3Q. Notably, the average total contract size of $2.2 million was highlighted as these were previously characterized as medium-sized deals.

Canaccord

Richard Close

Hold

downgrade

$30 -> $29

2025-05-15

Reason

Canaccord

Richard Close

Price Target

$30 -> $29

2025-05-15

downgrade

Hold

Reason

Canaccord analyst Richard Close lowered the firm's price target on HealthStream to $29 from $30 and keeps a Hold rating on the shares. The firm said they reported 1Q'25 results which fell below Canaccord and consensus estimates as well as a reduction in 2025 guidance.

Canaccord Genuity

Richard Close

Hold

Maintains

$29 → $30

2025-02-26

Reason

Canaccord Genuity

Richard Close

Price Target

$29 → $30

2025-02-26

Maintains

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on HealthStream to $30 from $29 and keeps a Hold rating on the shares. The firm said they reported a respectable quarter, with revenue above and adj-EBITDA only slightly below Canaccord and consensus estimates.

JMP Securities

Constantine Davides

Hold

Reiterates

n/a

2025-02-06

Reason

JMP Securities

Constantine Davides

Price Target

n/a

2025-02-06

Reiterates

Hold

Reason

Canaccord Genuity

Richard Close

Hold

Maintains

$28 → $29

2024-10-23

Reason

Canaccord Genuity

Richard Close

Price Target

$28 → $29

2024-10-23

Maintains

Hold

Reason

Canaccord raised the firm's price target on HealthStream to $29 from $28 and keeps a Hold rating on the shares. The firm said they posted another steady quarter and noted the the sales pipeline is strong across core product areas in CredentialStream, ShiftWizard, and API related products. Adoption of APIs and the Developer Portal has continued to gain traction, with the number of organizations and third-party developers accessing the portal roughly doubling in the last twelve months.

See All Ratings

Valuation Metrics

The current forward P/E ratio for HealthStream Inc (HSTM.O) is 33.85, compared to its 5-year average forward P/E of -31.88. For a more detailed relative valuation and DCF analysis to assess HealthStream Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-31.88

Current PE

33.85

Overvalued PE

369.98

Undervalued PE

-433.74

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

13.18

Current EV/EBITDA

9.93

Overvalued EV/EBITDA

15.78

Undervalued EV/EBITDA

10.58

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.81

Current PS

2.57

Overvalued PS

3.16

Undervalued PS

2.47